Abbott Q2 2026 earnings beat, raises full-year profit guidance

Abbott has announced its second-quarter 2026 earnings, which exceeded analyst expectations. The company reported higher-than-expected revenue and profit, driven by growth across its key segments. Following this positive performance, Abbott raised its full-year profit guidance, reflecting confidence in its ongoing business trajectory. The company's improved outlook suggests continued strength in its product lines and market position. This update is likely to influence investor sentiment positively and could impact Abbott's stock performance in the near term. The earnings report underscores Abbott's resilience amid market fluctuations and highlights its strategic focus on expanding its healthcare offerings.